72 бет - Істанбұлда (Түркия) емдеу

Areas of Interests

• Pediatric Genitourinary Reconstrictive Surgery
• Hypospadias
• Circumssion
• Oncological Surgery
• Congenital Abnormalities of Upper and Lower Urinary System
• Newborn Surgery
• Pediatric Abdominal Surgery

Education
 

• 1997 -  19 Mayıs University
• 1998 National Pediatric Surgery Congress Best Reearch Study
• 2001-  Kocaeli University
• 2007 – Kosova Government
• 2009 – Yeditepe University
• 2009 – Suudi Arab be Congeress Best Clinical Study

Experience
 

• FMV Işık Highschool
• İstanbul University Cerrahpaşa Medical Faculty
• Ondokuz Mayıs University
• Zeynep Kamil Childrens Hospital
• Kocaeli University Medical Faculty
• UT Southwestern Medical Center Pediatric Urology, Dallas, USA
• Ege University Medical Center Pediatric Urology
• Yeditepe University

Prof. Dr. Selami Sozubir has authored 65 scientific publications, which have received over 11,000 reads and nearly 1,000 citations, reflecting his strong contribution to the field of pediatric surgery and urology.

Areas of Interests

• Neuro-oncological surgery
• Spinal Surgery
• Pediatric Neurosurgery
• Peripheral Nerve Surgery
• Functional Neurosurgery and Algology

Education:

• Istanbul University, Faculty of Medicine
• Istanbul Okmeydani Training and Research Hospital

Experience:

• Liv Hospital Ulus
• Sisli Kolan Hospital
• Prof.Dr.Cemil Taşcıoğlu City Hospital
• Ardahan State Hospital

Research:

• Tumor markers and other laboratory findings in brain tumors
• Antiepileptic drugs in operated brain tumors
• Cervical corpectomy techniques
• Pre-emptive analgesia in spine surgeries

Publications:

• Uysal E, Cine HS, Yavuz AY, Cal MA. Impact of subventricular zone interaction on clinical outcomes in patients with intracerebral hematoma. Experimental Biomedical Research, 2024;7(3): 117–126. https://doi.org/10.30714/j-ebr.2024.215
• Çal MA, Yangı K. A Single-center Study Comparing Volumetric and Morphometric Measurements of Chiari Malformation in the Turkish Population. Eur Arc Med Res.2024 Mar;40(1):50-56. doi:10.4274/eamr.galenos.2024.24892.
• Avcı İ, Başkurt O, Şeker S, Kurtuluş Y, Çal MA. Rapid Recurrence of Glioblastoma After 12 Days Despite Gross Total Resection. Eur Arc Med Res.2024 Mar;40(1):62-65. doi:10.4274/eamr.galenos.2024.48615.
• Play MA. The relationship between vertebral compression rates and systemic inflammatory scores in osteoporotic vertebral fractures. Eur Rev Med Pharmacol Sci. 2024;28(3):959-968. doi:10.26355/eurrev_202402_35333
• Çal MA, Gök H. Retrospective Evaluation of the Effect of Surgery and CyberKnife on Recurrence and Neurological Deficits in Cases Diagnosed as Vestibular Schwannoma. Haydarpasa Numune Med J.2023;63 (1), 62 ‑67.doi:10.14744/hnhj.2022.45712
• Uysal E, Çal MA, Cine HS. The use of vancomycin powder in the compound depressed skull fractures. Clin Neurol Neurosurg. 2023;225:107570. doi:10.1016/j.clineuro.2022.107570
• Gök H, Şeker S, Peker HO, Çal MA, Altay T, Çelik S. A rare case report: Cervical subcutaneous and mediastinal emphysema due to mastoid fracture. A rare case report: Cervical subcutaneous and mediastinal emphysema due to mastoid fracture. Ulus Travma Emergency Surgery Journal . 2020;26(2):328 ‑330. doi:10.14744/tjtes.2019.02828
• Çınar N,Karaoğlan A,Midi A,Çal MA,Kelten B,Çakmak MA,Şahin Ş. Neuroprotective effect of ziprasidone: Preliminary results compared to haloperidol. J. Exp. Clin. Med ., 2014; 31:71 ‑75. doi : 10.5835/jecm.omu.31.02.002
• Karaoglan A, Cal MA, Orki A, Arpaozu BM, Colak A. Pneumorrhachis associated with bronchial asthma , subcutaneous emphysema and pneumomediastinum . Turkish Neurosurg . 2011;21(4):666 ‑668.
• Kelten B, Karaoğlan A, Cal MA, Akdemir O, Karancı T. Human immunodeficiency Bilateral epidural puncture in a patient infected with the virus Hematoma : Case report [ Bilateral epidural hematoma in a patient with Human immunodeficiency virus infection : a case report ]. Ulus Trauma Emergency Surgery Journal . 2013;19(3):267 ‑270. doi: 10.5505 /tjtes.2013.49799
• Karaoglan A, Akdemir O, Cinar N, et al. Correlation between leptin and pro- ‑inflammatory cytokines in cortical contusion injury model. Ulus Trauma Emergency Surgery Journal . 2011;17(4):298 ‑302. doi: 10.5505 /tjtes.2011.69077
• Cal MA, Kelten B, Akbas A, Akdemir O, Karaoglan A. Coexistence of spinal lipoma, ependymal cyst and dermoid cyst in neighboring localizations in context medullaris : A case report . HealthMed . 2013; 7(12):3227
• Canpolat A, Duman H, Akbaş A, Çal MA, Akdemir AO. Diffuse dysphagia and myeloradiculopathy presenting idiopathic skeletal hyperosteosis ( Forestier Disease). TC Maltepe University Medical Faculty Journal.2012;4(2),14 ‑17
• Karaoglan A, Kelten B,Akdemir AO,Çal MA. Lumbar spine presenting with radiculopathy spinal Chondroma : Case report. TC Maltepe University Medical Faculty Journal. 2011;3(3),28 ‑30
•  
• Istanbul Medical Chamber
• Turkish Neurosurgery Association
   

Education

Osmangazi University  Bachelor of Medicine 1995 – 2003

Celal Bayar University  Plastic, Reconstructive and  

Aesthetic Surgery Clinic 2009 – 2015

Experience

Kartal Dr. Lütfi Kırdar Training and Research Hospital, Plastic, Reconstructive and Aesthetic Surgery Clinic 2015 – 2021

Bahçeşehir University Faculty of Medicine Medical Park Göztepe Hospital  Plastic, Reconstructive and Aesthetic Surgery Clinic 2021 – 2021

Kartal Lütfi Kırdar State Hospital, Plastic, Reconstructive and Aesthetic Surgery Clinic 2019 – 2021

Lokman Hekim İstanbul Hospital - Plastic, Reconstructive and  

Aesthetic Surgery Clinic 2022 - Today  

Areas of Interests

• Breast cancer
• Lung cancer
• Colorectal cancers
• Gynecological and urogenital cancers
• Molecular Oncology

Education:

• Kızıltepe Anatolian High School 2001
• Dicle University Faculty of Medicine 2007
• Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
• Kartal City Hospital 2021
• Associate Professor of Medical Oncology 2023

Experience:

• Liv Hospital Ulus
• Adıyaman University Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital

Research:

• Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
• Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
• Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
• Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
• Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
• Publications:
• Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
• Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
• Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
• Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
• Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
• Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
• Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
• Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
• Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
• Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
• Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
• Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
• Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
• Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
• Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
• Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
• Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
• Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
• Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
• Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
• Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
• Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
• Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
• Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
• Book Writing:
• Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
• Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
• Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
• Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

Дәрігер глаукома, катаракта, тор қабығының ажырауы, диабеттік ретинопатия және астигматизм сияқты көз ауруларын диагностикалау және емдеу бойынша жиырма жылдан астам тәжірибесі бар тәжірибелі офтальмолог. Тор қабығы ауруларына маманданған дәрігер витреоретинальды хирургия және макулярлық операцияларда білікті. Дәрігер Phacik интраокулярлық линзалары бойынша зерттеулер жүргізіп, 300-ден астам офтальмологқа таратылған, бұл салаға айтарлықтай үлес қосты.<\/p>

Мүшеліктерге Түрік офтальмологиялық қауымдастығы, Еуропалық офтальмология кеңесі және Американдық офтальмология академиясы кіреді. Медициналық білім Улудаг университетінде аяқталды, Стамбулда қосымша мамандандыру және АҚШ-та алынған халықаралық тәжірибе.<\/p>

Areas of Interests

• Demyelinating Diseases and MS
• Peripheral Neuropathy and Motor Neuron Disease (ALS)
• Neuromuscular Junction Diseases (MG)

Education 

• M.Sc. Faculty of Medicine, Ondokuz Mayıs University  1990
• Specialization in Medicine  Neurology,  Ankara Training and Research Hospital 1997
• Minor Specialization  Clinical Neurophysiology, Medical Specialization Board 2011

Experience

• Doctor MoH Kastamonu and Samsun Health Center No. 7 1990-1992
• Dr. Res.Assist. Ankara Training and Research Hospital Neurology Clinic 1992-1997
• Assoc. Dr. Abant İzzet Baysal University Düzce Faculty of Medicine 1999-2006
• Assoc.Dr. Duzce University Faculty of Medicine 2007-2011
• Prof.Dr  Duzce University Faculty of Medicine  2011-

Education

• Undergraduate: Istanbul Faculty of Medicine, Istanbul University, 2007
• MSc (Internal Medicine Department): Marmara University Faculty of Medicine, 2012
• PhD (Hematology Clinic): Istanbul Training and Research Hospital, 2018
• Associate Professor (Hematology Clinic): Prof.Dr.Cemil Tascioglu Training and Research Hospital, 2019

Prof. Dr. Rafet Eren graduated from Istanbul Faculty of Medicine in 2007. He completed his Internal Medicine specialty training at Marmara University Faculty of Medicine in 2012. In 2018, he became a Hematology subspecialist at Istanbul Training and Research Hospital. In 2019, he was awarded the title of Associate Professor in the field of Hematology. Afterwards, he worked as a faculty member at Başakşehir Çam and Sakura City Hospital, Bozyaka Training and Research Hospital and Istinye University (Istinye University Bahçeşehir and Liv Hospital Vadistanbul) and is currently working at Biruni University Hospital. Dr. Rafet Eren is a member of Turkish Society of Hematology, Hematology Specialty Society and European Society of Hematology and speaks English fluently. He has around 50 publications in national and international refereed journals.

Scientific Memberships

• Turkish Hematology Association
• Hematology Specialty Society
• Turkish Internal Medicine Specialty Society
• European Society of Hematology
•  

Awards 

• Young Researcher Award (42nd National Hematology Congress), 2016
• Special Jury Paper Award (3rd Hematologic Oncology Congress), 2015
• Paper 3rd Prize (2nd Hematologic Oncology and Bone Marrow Transplantation Symposium), 2016

Dr. Ahmed Fatih Oguc is a specialist in gynecology and obstetrics. He is known for his skill and dedication to women’s health. He graduated from Trakya University Faculty of Medicine. He completed his specialization at Hacettepe University Faculty of Medicine.

Dr. Oguc has worked at leading healthcare institutions. He is committed to high standards of patient care and has earned strong patient satisfaction. He is a member of the Eskisehir Medical Chamber. This shows his commitment to professional growth and medical excellence.

Dr. Ersan Ates is an Orthopaedic Surgeon with over 25 years of surgical experience. He graduated from Trakya University Faculty of Medicine in 1990. He completed his specialist training in Orthopaedics and Traumatology at Haydarpaşa Numune Training and Research Hospital in 1995.

He provides care for bone, joint, and musculoskeletal conditions. His expertise includes trauma surgery; knee, hip, and shoulder procedures, including arthroscopy and joint replacement; and spine surgery for deformities, herniated discs, and trauma. He also treats sports injuries and pediatric orthopaedic conditions. He is known for precise surgery and patient-centered care focused on restoring mobility.

Dr. Murat Toygar Guler is a surgeon in orthopedics and otolaryngology (ENT). He graduated from Istanbul University Cerrahpaşa Faculty of Medicine. He completed his residency in Orthopedics and Traumatology at Bolu Abant Izzet Baysal University. He provides surgical and non-surgical care for musculoskeletal disorders.

Expertise: trauma surgery; knee, hip, and shoulder disorders; spinal deformities and herniated discs; sports injuries; pediatric orthopedics.

Experience: Bolu Abant Izzet Baysal University Orthopedics and Traumatology Clinic; Zonguldak Caycuma and Bolu Izzet Baysal State Hospitals; Private Atlas, Lokman Hekim, Medipol University Pendik, and Aksu Goztepe Hospitals. Known for precision and a patient-focused approach.

Dr. Haluk Inal is a urologic surgeon. He graduated from the GATA Faculty of Medicine. He completed his specialty training in urology at Haydarpaşa GATA Training and Research Hospital. He has decades of clinical and surgical experience. He provides advanced, minimally invasive urologic care.

Expertise: endourology (kidney stones, ureteral obstruction, urinary tract problems); prostate disease (BPH, prostate cancer); urologic oncology (kidney, bladder, testicular cancers); andrology and male health (erectile dysfunction, infertility); pediatric urology (undescended testis, hypospadias, congenital anomalies). He is known for precise, safe, and patient-focused care.

Areas of Interests

• Acute and chronic respiratory problems
• Respiratory tract infections
• Bronchoscopic diagnosis and treatment procedures
• Asthma
• Breathing problems during sleep
• Cystic fibrosis
• Tuberculosis

Education 

• Istanbul University Istanbul Faculty of Medicine (1991 - 1997) 

• Göztepe Training and Research Hospital, Department of Pediatrics, 1997 - 2002 

• Marmara University Faculty of Medicine, Department of Pediatric Chest Diseases, 2004 - 2007 

Experiences 

• Göztepe Training and Research Hospital Pediatrics Clinic, Pediatrics Specialist, 2002 - 2004 

• Sureyyapasa Chest Diseases Training and Research Hospital, Pediatric Chest Diseases Specialist, 2007 - 2010 

• Bezmialem Vakıf University Faculty of Medicine, Department of Pediatrics, Department of Pediatric Chest Diseases, Pediatric Chest Diseases Specialist, Lecturer, 2010 - 2023

Memberships 

• Turkish Pediatrics Institution, member of the supervisory board 

• Pediatric Chest Diseases Association, board member 

• Türk Toraks Derneği 

• Istanbul Tuberculosis Association 

• European Respiratory Society (ERS)

Medical Field of Special Interest and Activities 

Molecular Scanning 

Nuclear Oncology 

Radionuclide Treatments

Education and Experience 

2018 - Private LIV Hospital Ulus 

2015 - 2018 İstanbul Bilim University, Şişli Florence Nightingale Hospital 

2006 - 2015 Mersin University Master of Science in Nuclear Medicine 

2005 - 2006 Ankara Özel Denge Medical Centre 

2004 Hacettepe University Medical Faculty 

Specialization Training: 2000 - 2004 Hacettepe University Master of Science in Nuclear Medicine 

Undergraduate: 1993 - 1999 Hacettepe University Medical Faculty

Memberships 

Journal of Musculoskeletal Pain 

Turkish Journal of Clinical Sciences 

Molecular Imaging and Radionuclide Therapy 

Turkish Clinics Journal of Case Reports 

Journal of Clinical and Experimental Investigations 

Journal of Clinical and Analytical Medicine 

Acıbadem University Health Sciences Magazine 

Turkey Nuclear Medicine Association

Researches and Publications 

International Article: 35

Domestic Article: 18 

Chapter Author: 5 

Member of Broadcasting Advisory Board: 7 Domestic-International Magazines 

Internalnational Conference Presentations: 22

Areas Of Interest

Laser Prostate Surgeries (HoLEP, ThuFLEP) 

Robotic & Laparoscopic Surgery 

Robotic Transperineal Prostate MRI/Ultrasound Fusion Biopsy 

Urological Oncological Surgeries 

Female Urology 

Neuro-Urology 

Urethral Stenosis Surgeries (Graft Urethroplasty surgeries) 

Education 

Gulhane Military Medical Faculty 

Gülhane Military Medical Academy Department of Urology

Experience 

Liv Hospital Ulus 

KOLAN International Hospital 

Gülhane Training and Research Hospital 

Gulhane Military Medical Academy Research 

Evaluation of the effects of intracavernosal mitomycin-c administration on rat model in Peyroni’s disease (TÜBİTAK) 

Effects of intradetrusor decorin injection on tissue histopathology in rabbits with partial bladder outlet obstruction (TÜBİTAK)

Memberships 

Turkish Urological Association 

Society of Endourology 

European Society of Urology (EAU) 

American Urological Association (AUA

Medical Interests and Activities 

• Check-Up 

• Healthy Life 

• Sports Physiology 

• Anti-Doping Practices 

Education and Experience 

• • Check-Up and Healthy Life Center, Liv Hospital, Ulus
• • Medical Director, Remed Assistance, International Assistance Group
• • Memorial Hospital, Levent, Istanbul
• • Medical Director, Chief Physician, Clinica Gayrettepe
• • Studies with Prof. Dr. Ustun Korugan on Healthy Life and Sports Physiology
• • Director of Emergency Department, German Hospital, Taksim
• • Director of Emergency Department, International Hospital, Istanbul (1991 - 1995) • Residency in Family Practice, Haydarpasa Numune Hospital (1990 - 1995)
• • Emergency Career Study, NYU Medical Center, New York (1993 - 1994)
• • Doctor of Medicine Degree, Istanbul Faculty of Medicine, Istanbul University
• • Tarsus American College
•  
• Memberships 
•  
• • WONCA (World Organization of Family Doctors)
• • AAEM (American Academy of Emergency Medicine)
• • ISTM (International Society of Travel Medicine)
• • TAHUD (Turkish Association of Family Physicians)
• • WADA (World Anti-Doping Agency)
• • UEFA (Union of European Football Associations)
• • TFF (Anti-Doping Board of the Football Federation)
• • TBF (Anti-Doping Board of the Basketball Federation)
• • THE CLUB (Tarsus American College Alumni Association
•  
• Journal Editing, Membership for Publication and Scientific Advisory Boards 
•  
• • Columnist and Medical Vision Advisor, Sabah Newspaper (2002-Present)
• • EAP (Employee Assistance Program)
• • Anti-Doping Board, Turkish Football Federation
• • Basic and Intermediate Medical Training: Occupational training for employees of the leading Turkish pharmaceutical companies

Dr. Ayse Sercin Kulsoy is an obstetrician-gynaecologist and surgeon. She graduated from Istanbul University Faculty of Medicine in 1991. She has over 30 years of experience in women’s health care.

Expertise includes prenatal care; normal and caesarean deliveries; gynaecological surgery for fibroids, ovarian cysts, and endometriosis. She also evaluates and treats infertility and ovulation disorders, and offers assisted reproductive techniques. She manages menopause and provides preventive care, including cervical cancer screening and HPV management. Language: English.

Dr. Sertac Cicek is a renowned cardiovascular surgeon with over 40 years of medical experience. He has spent more than 30 years specializing in cardiac surgery, focusing on complex congenital and pediatric heart procedures. He trained at leading centers worldwide and completed fellowships at Texas Heart Institute, Mayo Clinic, and Children’s Hospital Los Angeles. This combination of fellowships is rare in the field.

Dr. Cicek is the Chief of Pediatric and Adult Cardiovascular Surgery at Liv Hospital Vadistanbul. He leads advanced surgical programs and performs specialized operations, including Ozaki aortic valve reconstructions, Ebstein anomaly repairs, and minimally invasive heart surgeries. He is also a pioneer in hybrid coronary artery bypass grafting (CABG).

Dr. Cicek holds ECFMG certification and active medical licenses in Turkey, Minnesota, and West Virginia. He has received several awards, such as the GATA 100th Anniversary Scientific Achievement Award and a Presidential Citation from the Asian Society for Cardiovascular Surgery. He is a founding member of the World Society for Pediatric and Congenital Heart Surgery and has been listed in Who’s Who in Medicine & Healthcare for 20 years.

Dr. Mustafa Aydın is an Internal Medicine specialist. He graduated from Gazi University Faculty of Medicine in 2009. He provides evidence-based care for adults, including diagnosis and treatment. He communicates in English.

His clinical focus includes chronic disease management, such as diabetes, hypertension, high cholesterol, and thyroid disorders. He treats gastrointestinal problems, including reflux, gastritis, ulcers, and liver diseases, and respiratory diseases like asthma and COPD. He manages infectious diseases. He provides preventive care with routine screenings, risk assessments, and personalized health plans.

Dr. Bercem Aycicek is an Associate Professor with over 20 years of experience in endocrinology and metabolic diseases. She is known for her strong clinical skills in treating complex hormonal and metabolic conditions. Her areas of expertise include diabetes, thyroid diseases, obesity, and resistant hypertension.

Dr. Aycicek is one of the few endocrinologists in Turkey with a focus on gender-affirming hormone therapy for trans individuals. She provides evidence-based and sensitive care. She also has a special interest in women’s health, managing issues such as irregular periods, delayed puberty, and metabolic bone diseases.

She earned her Associate Professorship at Health Sciences University Derince. Dr. Aycicek has worked in both public and private healthcare settings, helping to improve access to care. She is an active member of the Turkish Endocrine and Metabolism Society and the European Society of Endocrinology.